Disruption of TGF-β Signaling Prevents the Generation of Tumor-Sensitized Regulatory T Cells and Facilitates Therapeutic Antitumor Immunity
Data up to Jan 2025
Total Citations Per Year
Abstract
References (63)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
2006 • 6,720 citations
Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells
2010 • 5,969 citations
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.
1995 • 5,124 citations
Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3
2003 • 4,529 citations
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
2005 • 2,256 citations
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
2007 • 1,886 citations
The Concept of Immunological Surveillance
2015 • 1,586 citations
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance
2001 • 1,515 citations
Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell Ties
2006 • 1,403 citations
Natural versus adaptive regulatory T cells
2003 • 1,363 citations
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
1996 • 1,335 citations
Inducing and expanding regulatory T cell populations by foreign antigen
2005 • 1,245 citations
Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7
2004 • 1,123 citations
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
2005 • 998 citations
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease
2000 • 970 citations
TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells
2005 • 955 citations
Cutting Edge: Contact-Mediated Suppression by CD4+CD25+ Regulatory Cells Involves a Granzyme B-Dependent, Perforin-Independent Mechanism
2005 • 870 citations
Transforming Growth Factor-β Controls Development, Homeostasis, and Tolerance of T Cells by Regulatory T Cell-Dependent and -Independent Mechanisms
2006 • 769 citations
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
2001 • 759 citations
In Vivo Instruction of Suppressor Commitment in Naive T Cells
2004 • 726 citations
IL-10-Secreting Regulatory T Cells Do Not Express Foxp3 but Have Comparable Regulatory Function to Naturally Occurring CD4+CD25+ Regulatory T Cells
2004 • 654 citations
Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma
2005 • 618 citations
Cancer vaccines: between the idea and the reality
2003 • 616 citations
CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor β1 Production and Responsiveness
2002 • 614 citations
IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These Cells
2007 • 579 citations
Increased Regulatory T-Cell Fraction Amidst a Diminished CD4 Compartment Explains Cellular Immune Defects in Patients with Malignant Glioma
2006 • 570 citations
Natural Recovery and Protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ Regulatory Cells within the Central Nervous System
2005 • 545 citations
A Role for TGF-β in the Generation and Expansion of CD4+CD25+ Regulatory T Cells from Human Peripheral Blood
2001 • 540 citations
Tregs and rethinking cancer immunotherapy
2007 • 532 citations
Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival
1993 • 518 citations
T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells
2005 • 508 citations
Mechanism of Transforming Growth Factor β–induced Inhibition of T Helper Type 1 Differentiation
2002 • 501 citations
The Expression of the Regulatory T Cell–Specific Forkhead Box Transcription Factor FoxP3 Is Associated with Poor Prognosis in Ovarian Cancer
2005 • 494 citations
Cellular Mechanisms of Fatal Early-Onset Autoimmunity in Mice with the T Cell-Specific Targeting of Transforming Growth Factor-β Receptor
2006 • 454 citations
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
2006 • 448 citations
Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy
2007 • 425 citations
Immune resistance orchestrated by the tumor microenvironment
2006 • 422 citations
Induction offoxP3+ Regulatory T Cells in the Periphery of T Cell Receptor Transgenic Mice Tolerized to Transplants
2004 • 416 citations
Inactivation of the Type II Receptor Reveals Two Receptor Pathways for the Diverse TGF-β Activities
1993 • 388 citations
Cutting Edge: TGF-β Inhibits Th Type 2 Development Through Inhibition of GATA-3 Expression
2000 • 383 citations
Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer
2006 • 352 citations
Regulatory T cells and cancer
2007 • 325 citations
Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease
2004 • 322 citations
Sequential development of interleukin 2–dependent effector and regulatory T cells in response to endogenous systemic antigen
2005 • 296 citations
TGFβ signalling in control of T-cell-mediated self-reactivity
2007 • 294 citations
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines
2005 • 275 citations
Tumor-Induced Expansion of Regulatory T Cells by Conversion of CD4+CD25− Lymphocytes Is Thymus and Proliferation Independent
2006 • 252 citations
Inhibition of TGF-β2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies
2007 • 211 citations
Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma.
1993 • 208 citations
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 • 206 citations
Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity
2006 • 178 citations
Transforming growth factor beta1 in ductal carcinoma in situ and invasive carcinomas of the breast
1992 • 154 citations
Elevated serum levels of transforming growth factor-?1 in patients with colorectal carcinoma
1999 • 140 citations
Development of antitumor immune responses in reconstituted lymphopenic hosts.
2002 • 136 citations
The critical contribution of TGF‐β to the induction of Foxp3 expression and regulatory T cell function
2008 • 113 citations
A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
1998 • 99 citations
Phase I clinical trial of a TGF-β antisense-modified tumor cell vaccine in patients with advanced glioma
2006 • 97 citations
Homeostatic Proliferation Plus Regulatory T-Cell Depletion Promotes Potent Rejection of B16 Melanoma
2008 • 90 citations
Anti‐tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution
2003 • 85 citations
Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor.
1996 • 72 citations
Depletion of tumor‐induced Treg prior to reconstitution rescues enhanced priming of tumor‐specific, therapeutic effector T cells in lymphopenic hosts
2009 • 35 citations
Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response
2007 • 31 citations
CD28, TNF Receptor, and IL-12 Are Critical for CD4-Independent Cross-Priming of Therapeutic Antitumor CD8+ T Cells
2002 • 21 citations
Cited By (0)
No citing papers found in database